Blog
Recent paper outputs from the OpenSAFELY Community
In the past 6 months we’ve been very productive at OpenSAFELY publishing 21 peer-reviewed papers on a variety of topics.
The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19
In this guest blog, Katie Bechman describes the proof-of-principle pharmacovigilance study she conducted with the help of her team from King’s College London, which used OpenSAFELY to examine the safety of sotrovimab, paxlovid and molnupiravir in prehospital treatment of Covid-19.
Join us for our 2nd Annual OpenSAFELY Community Symposium!
Two days of talks and workshops on research, data infrastructure, and open science.
Recording technical decisions using ADRs
The Research Experience team explain how they’ve been recording decisions
We won an MRC award for open science
Most of the time, we like to keep things fairly formal on this blog - but if you’ll forgive us a small indulgence, today we’re going to blow our own trumpet a little. A couple of weeks ago, my colleague Rose Higgins and I went to an event in London where this Institute was awarded the Open Science Impact award, as part of the MRC Impact Prize. We were, needless to say, over the moon about it.
Research-ready computers in the cloud
Spend more time answering your research questions – and less time wrangling your computer – with GitHub Codespaces and the OpenSAFELY development container.
How COVID-19 affected sickness absences in England
Our new study looks at the rate that sick notes were issued for people with COVID-19, and how it changed over the course of the pandemic.
No increase to opioid prescribing during the COVID-19 pandemic in England
During the COVID-19 pandemic, there were no sustained increases in opioid prescribing.
How OpenSAFELY makes reproducible research easier
We describe the features of OpenSAFELY that encourage and support reproducible research.
DMARD monitoring during the COVID-19 pandemic
We describe some of our recent work investigating the impact of the COVID-19 pandemic on DMARD safety monitoring across >24 million patients’ records in England.